Intravenous (IV) Hydration Therapy Market To Reach $4.9 Billion, Globally, By 2033 At 7.8% CAGR: Allied Market Research
| Report Coverage |
Details |
| Forecast Period |
2024–2033 |
| Base Year |
2023 |
| Market Size in 2023 |
$2.3 billion |
| Market Size in 2033 |
$4.9 billion |
| CAGR |
7.8 |
| No. of Pages in Report |
220 |
| Segments Covered |
Service, Component, End User and Region. |
| Drivers |
Increase in prevalence of dehydration-related conditions |
| |
Growth in health and wellness trends |
| |
Rise in aging population |
| Opportunities |
Technological advancements |
| |
Increase in healthcare spending |
| Restraints |
High cost |
| |
Risk of complications |
For Purchase Related Queries/Inquiry -
Segment Highlights
The immune booster service is widely used in the IV hydration therapy market due to its effectiveness in enhancing the body's natural defenses. This treatment typically includes a combination of vitamins, such as Vitamin C and B-Complex, along with essential minerals and antioxidants. By directly infusing these nutrients into the bloodstream, the therapy quickly boosts the immune system, helping to prevent illnesses and accelerate recovery, making it popular among health-conscious individuals.
In addition, the rise in the use of medicated IV hydration therapy is fueled by its effectiveness in quickly replenishing essential nutrients and fluids. This therapy bypasses the digestive system, delivering vitamins, minerals, and medications directly into the bloodstream. It's popular among athletes, those seeking quick recovery from dehydration, and individuals aiming to boost energy levels or treat specific health conditions. Its convenience and immediate impact contribute to its growing popularity in wellness and medical circles.
Have a Question? Connect to our Analyst -
Furthermore, the need for IV hydration therapy is prominently observed in hospitals and clinics where patients require rapid rehydration due to conditions such as severe dehydration, electrolyte imbalances, or inability to take fluids orally. IV therapy allows healthcare providers to deliver fluids, electrolytes, and medications directly into the bloodstream, ensuring efficient absorption and swift relief of symptoms. Its controlled administration and ability to address critical medical needs make it a cornerstone in clinical settings for managing various health challenges.
Regional Outlook
The IV hydration therapy market varies regionally. North America leads due to high health awareness, advanced healthcare, and disposable income. Europe follows with growing wellness tourism and dehydration treatment. The Asia-Pacific region is rapidly expanding due to rising health awareness and better healthcare access. Latin America and the Middle East are also growing, driven by improved healthcare and medical tourism, despite regulatory challenges and higher costs.
Key Players
-
Davita
Nikkiso Co. Ltd.
Core IV Therapy, LLC
Cryojuvenate UK Ltd.
B. Braun Medical Inc.
Otsuka Pharmaceutical Co., Ltd.
NexGen Health
JW Life Science Corporation
Amanta Healthcare
Baxter International Inc.
Drip Hydration
The report provides a detailed analysis of these key players in the global intravenous (IV) hydration therapy market. These players have adopted different strategies such as expansion, product approval, product launch and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Recent Industry Development
-
In December 2022, The DRIPBaR, an IV vitamin therapy franchise growing rapidly across America, announced that they have partnered with entrepreneur, investor, and original "Shark Tank" shark, Kevin Harrington. Providing cells with the nutritional "fuel" through IV therapy, the franchise is experiencing tremendous annual growth as well as rapidly expanding across the nation.
In September 2021, B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, announced the launch of its new CARESAFE IV Administration Sets with Optional AirStop component. CARESAFE IV Sets are the first robust portfolio of IV administration sets in the U.S. market that are not made with polyvinyl chloride (PVC) and diethylhexyl phthalate (DEHP).
In September 2022, ScreenPro Security Inc.
announced that its wholly owned subsidiary Concierge Medical Consultants Inc. has introduced Intravenous Vitamin Therapy (IV Therapy) to its services in Toronto and Vancouver.
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link:
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences , Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web:
Follow Us on: LinkedIn
Twitter
Logo:
SOURCE Allied Market Research
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment